Award
Delivery Order #SPE2DR26F5ABZ
Delivery Order for Hydroxyurea Capsules to Federal Health Programs
Buyer
Defense Logistics Agency
Award Amount
$140.28
Ceiling
$140.28
Awarded
February 12, 2026
Period of Performance
Feb 12, 2026 – Feb 13, 2026
Identifier
SPE2DR26F5ABZ
NAICS
424210
This award is a delivery order contract issued under an existing long-term indefinite delivery vehicle (IDV) with AmerisourceBergen Drug Corporation, a prominent pharmaceutical distributor known for providing essential healthcare products. The contract involves the acquisition of Hydroxyurea 500 mg capsules, a critical pharmaceutical product used in therapeutic treatments, to support federal healthcare operations. The significance of this delivery order lies in its role within a larger multi-year contract that ensures a steady and reliable supply of vital medications to public health programs. The scope of work covers the prompt supply and delivery of the specified pharmaceutical over a short timeframe, reflecting a continuing commitment to medication availability. This award was made likely through a streamlined ordering process under the established contract, ensuring timely fulfillment without competitive rebidding. The performance period is notably brief, emphasizing rapid delivery to meet immediate agency needs. The contract builds upon the parent IDV awarded earlier, which spans multiple years and solidifies AmerisourceBergen's critical support role in government pharmaceutical procurement.
Description
4570821335!HYDROXYUREA 500 MG CAPSULE 100S